1/13
NS-Baseline2020_white.png

Your  R&D
department

Neuro-Sys is a research-intensive and innovative organization specializing in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields.

Award winning CRO

World's best CRO

Corporate Live Wire 2021

NEURO-SYS INC.png

Experts in
neurodegenerative
preclinical modelling
services

Latest
news

ALS-Drug-Development-Summit-logo-NEW-002-scaled.png

 EVENT  April 08, 2022

Neuro-Sys is Innovation Partner at the ALS Drug Development Summit in Boston, 24-26 May 2022.

The ALS Drug Development Summit is the definitive industry forum sharing cross-industry insight to rapidly advance life-changing ALS therapeutics.

> More

News_FENS.png

 EVENT  February 03, 2022

 

Neuro-Sys will be exhibiting at FENS in Paris, 9-13 July 2022.

Booth #36

FENS is the Europe’s largest international neuroscience conference, covering all domains in modern brain research from basic to translational research.

> More

AAIC22-purple-font.jpg

 EVENT  February 03, 2022

 

Neuro-Sys will be exhibiting at AAIC in San Diego, 31 July-3 August 2022.

Booth #421

 

The Alzheimer’s Association International Conference is the largest and most influential international meeting dedicated to advancing dementia science

> More

News_award.png

 AWARDS  August 29, 2021

 

Neuro-Sys inc. elected 2021 World's Best CRO of the year by Corporate Live Wire (UK).

We are very proud of this distinction, which congratulates several years of preclinical scientific excellence, the continuous efforts of our team of experts and the significant investments undertaken.

> More

design Book

 PUBLICATIONS  August 30, 2021

NSP01, a green extract of Huperzia serrata with neuroprotective effects related to synergistic action of Huperzine A and polyphenols

Noelle Callizot, Maria-Letizia Campanari, Laura Rouvière, Guillaume Jacquemot, Alexandre Henriques, Elnur Garayev and Philippe Poindron

> More

design Book

 PUBLICATIONS  August 19, 2021

AZP2006, a new promising treatment for Alzheimer’s and related diseases

N Callizot, C Estrella, S Burlet, A Henriques, C Brantis, M Barrier, M L Campanari, P Verwaerde

> More

News_PD.png

 PLATFORMS  March 8, 2021

 

The histology department is strengthened with the reinforcement of the team and the investment in the latest equipment.

> More

Biomek_edited.jpg